ArticleJournal of cancer research and clinical oncology2008

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

Xueling Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.